Clinical Trial Detail

NCT ID NCT01450384
Title Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Virginia Commonwealth University
Indications

Advanced Solid Tumor

Therapies

Pemetrexed Disodium + Sorafenib

Age Groups: adult

No variant requirements are available.